What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Gene
Naga Chalasani mainly focuses on Internal medicine, Gastroenterology, Fatty liver, Surgery and Nonalcoholic fatty liver disease.
His Internal medicine study frequently links to other fields, such as Endocrinology.
His research in Gastroenterology intersects with topics in Diabetes mellitus and Guideline, Biopsy, Pathology.
He has included themes like Proinflammatory cytokine, Placebo and Receptor expression in his Fatty liver study.
His study in Surgery is interdisciplinary in nature, drawing from both Odds ratio, Cohort study and Etiology.
His Nonalcoholic fatty liver disease research integrates issues from Chronic liver disease, Statin, Single-nucleotide polymorphism and Intensive care medicine.
His most cited work include:
- The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association (2522 citations)
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. (2005 citations)
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis (1964 citations)
What are the main themes of his work throughout his whole career to date?
Internal medicine, Gastroenterology, Cirrhosis, Nonalcoholic fatty liver disease and Liver disease are his primary areas of study.
In most of his Internal medicine studies, his work intersects topics such as Endocrinology.
Naga Chalasani interconnects Fibrosis, Steatohepatitis, Liver biopsy and Surgery in the investigation of issues within Gastroenterology.
His Cirrhosis research is multidisciplinary, incorporating elements of Hepatocellular carcinoma, Hepatitis C and Etiology.
His work carried out in the field of Nonalcoholic fatty liver disease brings together such families of science as Body mass index, Placebo and Steatosis.
The various areas that Naga Chalasani examines in his Liver disease study include Alcoholic liver disease, Alcoholic hepatitis and Cohort.
He most often published in these fields:
- Internal medicine (72.30%)
- Gastroenterology (44.89%)
- Cirrhosis (21.78%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (72.30%)
- Gastroenterology (44.89%)
- Cirrhosis (21.78%)
In recent papers he was focusing on the following fields of study:
Naga Chalasani mainly investigates Internal medicine, Gastroenterology, Cirrhosis, Liver disease and Nonalcoholic fatty liver disease.
Within one scientific family, he focuses on topics pertaining to Endocrinology under Internal medicine, and may sometimes address concerns connected to Antibody.
His Gastroenterology research is multidisciplinary, incorporating perspectives in Hepatocellular carcinoma, Placebo and Fatty liver.
His research integrates issues of Odds ratio, Proportional hazards model, Surgery, Confidence interval and Acute kidney injury in his study of Cirrhosis.
His Liver disease study combines topics in areas such as Inflammation, Cohort study, Transplantation and Comorbidity.
Naga Chalasani has researched Nonalcoholic fatty liver disease in several fields, including Body mass index, Steatosis, Liver biopsy, Portal venous pressure and Steatohepatitis.
Between 2019 and 2021, his most popular works were:
- Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension (51 citations)
- Vitamin E Improves Transplant-Free Survival and Hepatic Decompensation Among Patients With Nonalcoholic Steatohepatitis and Advanced Fibrosis. (42 citations)
- Impact of obeticholic acid on the lipoprotein profile in patients with non-alcoholic steatohepatitis. (30 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
His primary areas of study are Internal medicine, Cirrhosis, Gastroenterology, Liver disease and Nonalcoholic fatty liver disease.
His work in Internal medicine addresses issues such as Endocrinology, which are connected to fields such as Immune system.
His studies in Cirrhosis integrate themes in fields like Acute kidney injury, Hepatocellular carcinoma, Hemostasis and Receiver operating characteristic.
Naga Chalasani integrates Gastroenterology with Extracellular vesicle in his research.
His Liver disease research is multidisciplinary, relying on both Alcoholic liver disease, Cohort study, Hospitalized patients, Thromboelastography and Inclusion and exclusion criteria.
His Nonalcoholic fatty liver disease research includes themes of Esophageal varices, Placebo and Portal venous pressure.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
